A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome

Clinical trial NCT07281079 · RECRUITING

Trial details

NCT number: NCT07281079
Sponsor: Neuren Pharmaceuticals Limited
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Phelan-McDermid Syndrome

Start date: 2025-11-12
Primary completion: 2027-10-31
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.